Menu

Recent Interviews

Ryan Jackson, CEO, Newlox Gold Ventures Corp.

Ryan Jackson
CEO | Newlox Gold Ventures Corp.
60 Laurie Crescent, V7S 1B7 West Vancouver (CAN)

info@newloxgold.com

+1 778 738 0546

Newlox CEO Ryan Jackson on building a green gold producer with a rapid growth trajectory


Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


30. October 2020 | 13:26 CET

Sartorius, Intel, Royal Helium: How investors invest in the future

  • Investments
Photo credits: pixabay.com

The crisis divides the economy: On the one hand, some industries are forced into change or disappear from the market. On the other hand, there are also winners of the crisis: shares in the healthcare sector profit from the increasing demand for healthcare or laboratory products. Chip manufacturers are happy about full order books and are beneficiaries of the growing digitalization. The megatrend of the past few years has gained additional momentum due to the pandemic.

time to read: 3 minutes by Nico Popp


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


Sartorius: What follows after a 120% return on investment?

The shares of the Goettingen-based Company, Sartorius, were quickly named as a beneficiary of the pandemic. Indeed, the share price performance of the past years looks very impressive: The share price climbed like clockwork. Sartorius manufactures single-use products for the production of drugs and other laboratory supplies. At a time when millions of people are tested for a Covid-19 infection every week, and the race for a vaccine is entering a hot phase, the share price appears attractive.

The Company is also optimistic and recently increased its forecast. Although Sartorius has an ambitious valuation, additional business due to the pandemic is very likely. On a one-year horizon, the share price climbed nearly 120%. Although the dividend is only available in homeopathic doses, this is not important for investors. The share is a solid growth stock in a promising industry - but it is also a bit expensive.

Intel: chip giant does not get off the ground

In contrast, the Intel share is not expensive and currently offers an entry in the low double-digit price-earnings ratio range. Chips from Intel are found in many desktop PCs and laptops. The chip giant is also involved in many other areas and is indirectly considered an attractive investment in the leisure sector - gaming has long been a billion-dollar market, and the fastest chips often come from Intel. The chip manufacturer also covers topics like the Internet of Things.

In the year, there were rumors that Intel might in future rely on contract manufacturers from Taiwan for the production of chips. These plans have been rejected as it is vital to customers that high-quality chips come from Intel. The processors rightly have the reputation of being of high quality and often cost a little more than, for example, competing products from AMD. The share price trend shows the fact that digitization alone as a buzzword is no longer sufficient to attract investors. Intel shares have lost 26.2% over the past twelve months. Despite a low valuation and a stable dividend yield of well over 2%, the share currently shows no momentum.

Royal Helium: Investment in booming industries with a difference

Shareholders of the Canadian Company Royal Helium cannot complain about dynamics - the value has been volatile for months. The Company is searching for the noble gas helium in the south of the Canadian province of Saskatchewan. The gas is used as a propellant or packing gas and, is also used in medicine and chip manufacture. It is also known as a carrier gas for balloons and airships. Royal Helium operates in a traditional production area for the gas and expects long-term growth from its production.

As analysts from Cormark Securities report, the growing demand for helium could lead to a supply shortfall in the coming years, which will become even more significant. In the USA, about one-third of the need for helium comes from the medical sector. The noble gas is used in magnetic resonance imaging equipment. Other significant areas of application in the USA are carrier gas (17%), laboratory instruments (14%) or chip production (5%). In total, the analysts distinguish more than eight areas of application.

Given the market perspective around helium, the analysts of Cormark Securities see a price target of CAD 0.80 for the share - that is about 100% above the current price. Given the market capitalization of only about EUR 12.8 million, the share must be considered highly speculative. However, rapid price increases are possible, especially with such small caps. While shares like Sartorius are already expensive and stocks like Intel are not picking up speed, Royal Helium could be worth considering for speculative investors. After all, the helium market is also profiting from the booming healthcare and semiconductor industries.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

25. November 2020 | 11:44 CET | by Nico Popp

Sartorius, Drägerwerk, Desert Gold: Vaccines for the portfolio

  • Investments

The crisis is on the home stretch. Several vaccines have been found and are about to be approved. But it will still take a while before the pandemic is defeated: millions of people need to be vaccinated. Usually, two doses of vaccine are required for this purpose, which must be administered at specific intervals. This Herculean logistical task must succeed in many countries if normality is to be restored. This much seems inevitable: 2021 will still be under the influence of the virus. Corona also leaves its mark on the capital market, whether directly or indirectly.

Read

25. November 2020 | 11:15 CET | by Stefan Feulner

Moderna, Triumph Gold, BioNTech - bet on winners!

  • Investments

Gold has not made it out - for the time being. Due to the decision of the Americans pro Joe Biden and the very successful developments regarding a vaccine against the coronavirus, the precious yellow metal went downhill for the time being. The correction may well continue a little further. However, in the past, these setbacks were lucrative with anti-cyclical entry opportunities. Therefore, one should use the time now to take a closer look at promising gold mines.

Read

24. November 2020 | 10:38 CET | by Stefan Feulner

BYD, BIGG Digital Assets, NEL ASA - Get rich with these trends!

  • Investments

Hydrogen, blockchain or e-mobility, these new technologies are currently keeping investors busy. Leading stocks from the respective industries have gained several hundred percent in the past months. But these trends are only at the beginning of their development. In addition to the top performers, second and third-tier companies with novel business models are gradually moving forward. Further outperformers seem preprogrammed.

Read